Adoption remained modest until recent years as GLP-1 drug claims rose from 6.9 percent in 2023 to 10.5 percent in 2025
Designed for physically active adults, fitness enthusiasts and individuals following a structured exercise routine, these capsules can be included as part of a balanced sports-nutrition plan
The review documented the glucose-dependent stimulation of insulin secretion, decrease of gastric emptying, inhibition of food intake, natriuresis and diuresis, and modulation of -cell proliferation as key pancreatic and gastrointestinal actions
Some research firms, such as Research and Markets, project the market to grow by a compound annual growth rate (CAGR) of 11.1%, ending 2035 with a valuation of as much as $157.5 billion
Balavandy and Z
In fact, going beyond 500 mcg daily hasnt shown significantly greater fat-loss outcomes (related trial safety/efficacy background)